Postoperative Opioid Utilization Following Benign Gynecological Surgery
ACOG ePoster. Movilla P. Apr 27, 2018; 211497
Peter Movilla
Peter Movilla
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction: There is increasing concern for opioid over-prescribing patterns, with nearly quadrupling of the number of opioid prescriptions in the United States since 1999. There are no guidelines for directing the opioid prescription patterns following benign gynecological surgery.

Methods: We are conducting a prospective study assessing postoperative pain prescriptions and medication usage via telephone survey.


Results: Our preliminary results show that 54 patients underwent a benign gynecological surgery at the University of California San Francisco from August to September 2017. 45 (83.3%) patient's received an opioid prescription. 15 (27.8%) were hysteroscopy procedures, 31 (57.4%) laparoscopy, 5 (9.3%) laparotomy, and 3 (5.6%) categorized as others. On average 41.7 morphine milligram equivalents (MME) of opioids were prescribed following hysteroscopy, 176.0 MME following laparoscopy, 260.0 MME following laparotomy, and 83.3 MME following others.

33 (61.1%) patients completed the telephone survey. On average 25.6 MME of opioids were not utilized by postoperative day seven following hysteroscopy, 116.6 MME following laparoscopy, 298.1 MME following laparotomy, and 29.1 MME following others.

26 patients completed the telephone survey and utilized opioids. 46.2% would keep excess opioids for future use. 23.1% would dispose of excess opioids.

Conclusion/Implications: Opioid analgesics are a major component of current gynecological postoperative pain management. On average patients receive in excess an equivalent of 15.5 tablets of 5mg oxycodone following laparoscopic surgery not utilized by postoperative day seven. A majority of patients are keeping excess opioids for utilization outside of their intended purpose.

Data collection is ongoing and estimate an additional 100 patients for the completed study.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings